涩里番

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

An open solution to improving research reproducibility

Published: 18 December 2024

Academic and industry scientists collaborate on a new method to characterize research antibodies

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Open Science project funded for $1.5M

Published: 12 November 2024

YCharOS antibody characterization platform addresses the 鈥渞eproducibility crisis鈥 in research...

Project to create AI model for ALS receives G茅nome Qu茅bec funding

Published: 17 March 2025

$400,000 will fuel public-private collaboration to discover new disease biomarkers...

At-home neurological disorder diagnosis project receives major funding

Published: 8 November 2024

$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson鈥檚 disease...

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Published: 14 March 2025

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...

AI analysis of healthcare records reveals key factors in autism diagnosis

Published: 26 March 2025

Scientists argue the criteria we use for diagnosing autism may need revision...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone鈥檚 impact on brain cancer immunotherapy...

Pages

Back to top